论文部分内容阅读
目的评价高血压脑出血采取尼莫地平治疗的临床效果及价值。方法将86例高血压脑出血患者纳入研究,按随机数字表法分为两组,每组43例,对照组患者采取常规方法进行治疗,观察组患者以常规方法为基础,进一步采取尼莫地平治疗,对比两组治疗效果。结果在治疗总有效率上,观察组为95.35%,明显高于对照组(65.12%),差异有统计学意义(P<0.05)。在血肿量、神经功能缺损评分上,治疗前两组比较差异未见统计学意义(P>0.05);治疗后,观察组血肿量与对照组相比明显减少(P<0.05),神经功能缺损评分与对照组相比明显降低(P<0.05)。结论高血压脑出血患者采取尼莫地平治疗效果显著,可降低血肿量,并使患者的神经功能状态得到有效改善,进而达到提升临床疗效的目的,值得在临床推广应用。
Objective To evaluate the clinical efficacy and value of nimodipine in the treatment of hypertensive intracerebral hemorrhage. Methods Eighty-six patients with hypertensive intracerebral hemorrhage were enrolled in the study. According to the random number table, the patients were divided into two groups (43 in each group). The patients in the control group were treated by conventional methods. The patients in the observation group were further treated with nimodipine Treatment, compared with two groups of treatment. Results The total effective rate of observation group was 95.35%, which was significantly higher than that of control group (65.12%), the difference was statistically significant (P <0.05). Compared with the control group, the hematoma volume in the observation group was significantly decreased (P <0.05), and the neurological deficits in the hematoma volume and neurological deficit scores were not statistically significant (P> 0.05) The score was significantly lower than that of the control group (P <0.05). Conclusion Nimodipine is effective in patients with hypertensive intracerebral hemorrhage, which can reduce the hematoma volume and improve the neurological status of patients effectively, so as to achieve the goal of improving clinical efficacy. It is worth popularizing in clinical application.